Latest updates on the coronavirus and heart disease
Advocating at the Global Level to Improve Heart Health for Everyone:
Tackling CVD to Achieve the SDGs and UHC
Home > Global Advocacy
Advocating for fiscal policies, including taxes on tobacco, alcohol and sugar-sweetened beverages, to help fund UHC.
Air pollution is a significant risk factor for CVD and as such must urgently be addressed through research, education, and policy change.
RHD is a preventable, treatable form of cardiovascular disease that affects over 33 million people around the world, chiefly in low-resource settings.
As smoking prevalence continues to climb in the developing world, we are mobilizing the CVD community in the fight against tobacco.
WHF is the only organization representing the CVD community in Official Relations with the WHO, the global authority on public health policy.
Our advocacy experts work closely with the UN, its agencies, and other international bodies to influence global policies, strategies and funding.
This Committee is composed of experts representing each WHO Region. It serves to inform and approve science-based policy proposals.
The TEG supports the development of WHF position papers, external statements, and internal policies to advance progress on global tobacco control.
The APEG guides the work of WHF in the area of air pollution and CVD, identifying areas for further research and prioritizing key advocacy objectives.
The Global Coalition for Circulatory Health brings together international, regional and national stakeholders in circulatory health.
Coalition of International NGOs call for Equitable access for vaccines and treatment during COVID-19 pandemic
Statement on the EU-led Draft Resolution on Strengthening WHO Preparedness and Response to Health Emergencies
WHO Executive Board 148: Keeping CVD at the center of the global health debate